UCB Stock CINNOBER BOAT
Stocks
0NZT
BE0003739530
Pharmaceuticals
OTC Markets Traded| Market Cap | 46.31B 52.84B 43.03B 39.52B 74.42B 5,103B 75.6B 512B 200B 2,496B 198B 194B 8,619B | P/E 2026 * |
26.1x | P/E 2027 * | 20.7x |
|---|---|---|---|---|---|
| Enterprise Value | 46.07B 52.57B 42.81B 39.31B 74.04B 5,076B 75.2B 510B 199B 2,483B 197B 193B 8,574B | EV / Sales 2026 * |
5.39x | EV / Sales 2027 * | 4.56x |
| Free-Float |
61.59% | Yield 2026 * |
0.6% | Yield 2027 * | 0.62% |
Last Transcript: UCB
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2014-12-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 2020-06-30 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2011-12-31 | |
| Director/Board Member | 67 | 2014-12-31 | |
| Director/Board Member | 56 | 2014-04-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 52.97B | |
| -3.56% | -0.75% | +19.37% | -11.36% | 68.69B | |
| -1.65% | +37.20% | +37.20% | +37.20% | 43.61B | |
| -2.83% | -4.08% | -53.81% | -55.84% | 40.75B | |
| -2.67% | +3.02% | +61.18% | -28.55% | 29.99B | |
| -2.67% | -13.89% | +87.50% | -54.07% | 23.67B | |
| -1.36% | +0.79% | +71.85% | +80.50% | 23.45B | |
| +0.11% | +2.44% | +4.06% | +181.25% | 20.46B | |
| -0.39% | +2.03% | +72.19% | +122.26% | 16.66B | |
| +0.25% | -1.70% | +80.09% | +142.19% | 16.16B | |
| Average | -1.14% | -0.09% | +42.18% | +45.95% | 31.49B | |
| Weighted average by Cap. | -1.56% | +0.35% | +31.51% | +22.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.54B 9.75B 7.94B 7.29B 13.73B 941B 13.94B 94.49B 36.95B 461B 36.58B 35.79B 1,590B | 9.64B 11B 8.96B 8.23B 15.5B 1,062B 15.74B 107B 41.71B 520B 41.29B 40.4B 1,795B |
| Net income | 1.77B 2.02B 1.64B 1.51B 2.84B 195B 2.89B 19.58B 7.65B 95.41B 7.58B 7.41B 329B | 2.28B 2.6B 2.12B 1.94B 3.66B 251B 3.72B 25.19B 9.85B 123B 9.75B 9.54B 424B |
| Net Debt | -242M -276M -225M -207M -389M -26.69B -395M -2.68B -1.05B -13.06B -1.04B -1.01B -45.08B | -2.32B -2.65B -2.16B -1.98B -3.73B -256B -3.79B -25.7B -10.05B -125B -9.95B -9.73B -432B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
